The role of the lysophosphatidic acid (LPA) receptor 1 in developmental alveolarization

M. Funke, L. Knudsen, S. Matthieu, B. Fontaine, J. Chun, M. Ochs, A. Tager (Berne, Switzerland; Hannover, Germany; Boston, Indianapolis, La Jolla, United States Of America)

Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Session: Translational studies in chronic repair and remodelling in the lung
Session type: Oral Presentation
Number: 3331
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Funke, L. Knudsen, S. Matthieu, B. Fontaine, J. Chun, M. Ochs, A. Tager (Berne, Switzerland; Hannover, Germany; Boston, Indianapolis, La Jolla, United States Of America). The role of the lysophosphatidic acid (LPA) receptor 1 in developmental alveolarization. Eur Respir J 2013; 42: Suppl. 57, 3331

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats
Source: International Congress 2015 – Neonatal and paediatric intensive care
Year: 2015

Involvement of coactivator associated arginine methyltransferase 1 (CARM1) in development of elastase-induced progressive emphysema
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013


A role for the accessory type III transforming growth factor β receptor (Tgfbr3) in lung alveolarisation
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Promotion of pulmonary fibroblast migration by bile acid receptor through activation of TGF-ß1/p-Smad3 signaling pathway
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018

Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

Therapeutic efficacy of a novel LPA1 receptor antagonist, UD-009, in a bleomycin-induced pulmonary fibrosis model
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014

Cross-talk of circadian and immune system in neuropeptide S receptor 1 deficient mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013

ATF3 regulates PINK1 transcription in lung epithelial cells of the aging lung
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016

Mesenchymal Tsc2 deficiency causes retarded lung alveolarization and polycystic kidney lesion
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016

Changes in epithelial barrier components E-cadherin, Beta-catenin, EGR with steroid treatment in murine model of asthma
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015


Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015

Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Interaction of dietary fatty acids with obesity induced cytokines in primary human pulmonary fibroblasts
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


Deletion of peroxiredoxin 6 potentiates OVA-induced asthma epithelial-mesenchymal transition through EGFR pathway
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Regulation of autophagy in amiodarone induced pulmonary fibrosis
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013

Transforming growth factor alpha expression in a transgenic mouse model impairs lung and diaphragm mechanics
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015

IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015


Cigarette smoke-induced lung inflammation is skewed in estrogen receptor-alpha deficient mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013


Altered expression of histamine receptor 4 and MAPK kinase in childhood asthma
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015